KYTHERA BIOPHARMACEUTICALS I's ticker is KYTH and the CUSIP is 501570105.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2015 | $179,000 | -0.6% | 2,388 | 0.0% | 0.04% | -7.5% |
| Q2 2015 | $180,000 | -18.2% | 2,388 | -45.6% | 0.04% | -31.0% |
| Q1 2015 | $220,000 | +44.7% | 4,388 | 0.0% | 0.06% | +13.7% |
| Q4 2014 | $152,000 | +5.6% | 4,388 | 0.0% | 0.05% | 0.0% |
| Q3 2014 | $144,000 | -28.0% | 4,388 | 0.0% | 0.05% | -55.7% |
| Q3 2013 | $200,000 | – | 4,388 | – | 0.12% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| AlpInvest Partners B.V. | 33,271 | $1,277,000 | 4.55% |
| Palo Alto Investors LP | 949,959 | $36,450,000 | 2.71% |
| Redmile Group, LLC | 560,356 | $21,501,000 | 2.61% |
| SENZAR ASSET MANAGEMENT, LLC | 124,900 | $4,792,000 | 1.83% |
| Aureus Asset Management, LLC | 152,662 | $5,858,000 | 1.46% |
| PFM Health Sciences, LP | 952,715 | $36,556,000 | 0.73% |
| REGENTATLANTIC CAPITAL LLC | 176,454 | $6,771,000 | 0.63% |
| Polar Capital LLP | 519,398 | $19,927,000 | 0.42% |
| FNY Managed Accounts LLC | 2,500 | $95,925,000 | 0.35% |
| Partner Investment Management, L.P. | 36,173 | $1,388,000 | 0.28% |